These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16396000)

  • 1. Methods for assessing noninferiority with censored data.
    Freitag G
    Biom J; 2005 Feb; 47(1):88-98; discussion 99-107. PubMed ID: 16396000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic equivalence--clinical issues and statistical methodology in noninferiority trials.
    Munk A; Trampisch HJ
    Biom J; 2005 Feb; 47(1):7-9; discussion 99-107. PubMed ID: 16395992
    [No Abstract]   [Full Text] [Related]  

  • 3. Superior safety in noninferiority trials.
    Bristol DR
    Biom J; 2005 Feb; 47(1):75-81; discussion 99-107. PubMed ID: 16395998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A regulatory perspective on choice of margin and statistical inference issue in non-inferiority trials.
    Hung HM; Wang SJ; O'Neill R
    Biom J; 2005 Feb; 47(1):28-36; discussion 99-107. PubMed ID: 16395994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statistical methods for the analysis of two-arm non-inferiority trials with binary outcomes.
    Wellek S
    Biom J; 2005 Feb; 47(1):48-61; discussion 99-107. PubMed ID: 16395996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biostatistical assessment of mutagenicity studies by including the positive control.
    Hauschke D; Slacik-Erben R; Hensen S; Kaufmann R
    Biom J; 2005 Feb; 47(1):82-7; discussion 99-107. PubMed ID: 16395999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Problems with existing procedures to calculate exact unconditional P-values for non-inferiority/superiority and confidence intervals for two binomials and how to resolve them.
    Röhmel J
    Biom J; 2005 Feb; 47(1):37-47; discussion 99-107. PubMed ID: 16395995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Choice of delta: requirements and reality--results of a systematic review.
    Lange S; Freitag G
    Biom J; 2005 Feb; 47(1):12-27; discussion 99-107. PubMed ID: 16395993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Testing superiority and non-inferiority hypotheses in active controlled clinical trials".
    Röhmel J; Hauschke D
    Biom J; 2006 Feb; 48(1):174-5; author reply 176. PubMed ID: 16544822
    [No Abstract]   [Full Text] [Related]  

  • 10. Active-control clinical trials to establish equivalence or noninferiority: methodological and statistical concepts linked to quality.
    Gomberg-Maitland M; Frison L; Halperin JL
    Am Heart J; 2003 Sep; 146(3):398-403. PubMed ID: 12947355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic equivalence investigations: statistical considerations.
    Röhmel J
    Stat Med; 1998 Aug 15-30; 17(15-16):1703-14. PubMed ID: 9749441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interpretation and inference in noninferiority randomized controlled trials in drug research.
    Wangge G; Klungel OH; Roes KC; de Boer A; Hoes AW; Knol MJ
    Clin Pharmacol Ther; 2010 Sep; 88(3):420-3. PubMed ID: 20668448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testing superiority and non-inferiority hypotheses in active controlled clinical trials.
    Tsong Y; Zhang JJ
    Biom J; 2005 Feb; 47(1):62-74; discussion 99-107. PubMed ID: 16395997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninferiority drug trials fail to report adequate methodological detail: an assessment of noninferiority trials from 2010 to 2015.
    Hong J; Tung A; Kinkade A; Tejani AM
    J Clin Epidemiol; 2019 Apr; 108():144-146. PubMed ID: 30529004
    [No Abstract]   [Full Text] [Related]  

  • 15. Randomization as a basis for inference in noninferiority trials.
    Wiens BL
    Pharm Stat; 2006; 5(4):265-71. PubMed ID: 17128425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statistical issues and recommendations for noninferiority trials in oncology: a systematic review.
    Tanaka S; Kinjo Y; Kataoka Y; Yoshimura K; Teramukai S
    Clin Cancer Res; 2012 Apr; 18(7):1837-47. PubMed ID: 22317762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A bootstrap-based test for establishing noninferiority in clinical trials.
    Chen M; Kianifard F; Dhar SK
    J Biopharm Stat; 2006 May; 16(3):357-63. PubMed ID: 16724490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of reporting of noninferiority and equivalence randomized trials.
    Le Henanff A; Giraudeau B; Baron G; Ravaud P
    JAMA; 2006 Mar; 295(10):1147-51. PubMed ID: 16522835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-arm noninferiority trials with a prespecified margin for inference of the difference in the proportions of binary endpoints.
    Hida E; Tango T
    J Biopharm Stat; 2013; 23(4):774-89. PubMed ID: 23799810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practical issues in equivalence trials.
    Ebbutt AF; Frith L
    Stat Med; 1998 Aug 15-30; 17(15-16):1691-701. PubMed ID: 9749440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.